Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + Docetaxel + Cisplatin in Metastatic Breast Cancer
NCT01025349Phase 2Completed
- Sponsor
- Taipei Medical University Hospital
- Start
- Jan 2005
- Primary completion
- Sep 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by Taipei Medical University Hospital. Started Jan 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01025349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01025349.